These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 18798508)

  • 21. [Expression and clinical significance of uPA and PAI-1 in epithelial ovarian cancer].
    Cai Z; Li YF; Liu FY; Feng YL; Hou JH; Zhao MQ
    Ai Zheng; 2007 Mar; 26(3):312-7. PubMed ID: 17355798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apoptosis in epithelial ovarian tumours Prognostic significance of clinical and histopathologic factors and its association with the immunohistochemical expression of apoptotic regulatory proteins (p53, bcl-2 and bax).
    de la Torre FJ; García A; Gil-Moreno A; Planaguma J; Reventos J; Ramón y Cajal S; Xercavins J
    Eur J Obstet Gynecol Reprod Biol; 2007 Jan; 130(1):121-8. PubMed ID: 16876311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prognostic significance of Bcl-2 and p53 expression in ovarian carcinoma.
    Herod JJ; Eliopoulos AG; Warwick J; Niedobitek G; Young LS; Kerr DJ
    Cancer Res; 1996 May; 56(9):2178-84. PubMed ID: 8616869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential expression of Bcl-2, Bcl-XL and p53 in colorectal cancer.
    Han HS; Park YM; Hwang TS
    J Gastroenterol Hepatol; 2006 Jul; 21(7):1108-14. PubMed ID: 16824061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ovarian serous carcinoma: relationship of p53 and bcl-2 with tumor angiogenesis and VEGF expression.
    Crasta JA; Mishra S; Vallikad E
    Int J Gynecol Pathol; 2011 Nov; 30(6):521-6. PubMed ID: 21979585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prophylactic oophorectomy: a morphologic and immunohistochemical study.
    Schlosshauer PW; Cohen CJ; Penault-Llorca F; Miranda CR; Bignon YJ; Dauplat J; Deligdisch L
    Cancer; 2003 Dec; 98(12):2599-606. PubMed ID: 14669279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclin E mRNA overexpression in epithelial ovarian cancers: inverse correlation with p53 protein accumulation.
    Sawasaki T; Shigemasa K; Shiroyama Y; Kusuda T; Fujii T; Parmley TH; O'Brien TJ; Ohama K
    J Soc Gynecol Investig; 2001; 8(3):179-85. PubMed ID: 11390254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epithelial cell turnover, p53 and bcl-2 protein expression during oncogenesis of early and advanced gastric cancer in a Western population.
    Triantafyllou K; Kitsanta P; Karamanolis DG; Kittas C; Ladas SD
    Dig Liver Dis; 2008 Jan; 40(1):39-45. PubMed ID: 18063429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD44s expression, in benign, borderline and malignant tumors of ovarian surface epithelium. Correlation with p53, steroid receptor status, proliferative indices (PCNA, MIB1) and survival.
    Zagorianakou N; Stefanou D; Makrydimas G; Zagorianakou P; Briasoulis E; Karavasilis B; Agnantis NJ
    Anticancer Res; 2004; 24(3a):1665-70. PubMed ID: 15274338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Expression of GLUT-1, p63 and DNA-Pkcs in serous ovarian tumors and their significance].
    Shao SL; Cai Y; Wang QH; Yan LJ; Zhao XY; Wang LX
    Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):697-700. PubMed ID: 18246802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of apoptosis and apoptosis-related proteins in microvessels of human ovarian epithelial tumors.
    Gurevich P; Ben-Hur H; Berman V; Huszar M; Tendler Y; Zusman I
    Anticancer Res; 2001; 21(2B):1335-8. PubMed ID: 11396209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation between BRCA1 expression and apoptosis-related biological parameters in sporadic breast carcinomas.
    Yang Q; Yoshimura G; Nakamura M; Nakamura Y; Suzuma T; Umemura T; Mori I; Sakurai T; Kakudo K
    Anticancer Res; 2002; 22(6B):3615-9. PubMed ID: 12552965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Downregulation of KAI1 metastasis suppressor protein is associated with a dismal prognosis in epithelial ovarian cancer.
    Schindl M; Birner P; Breitenecker G; Oberhuber G
    Gynecol Oncol; 2001 Nov; 83(2):244-8. PubMed ID: 11606078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathological significance of DEK overexpression in serous ovarian tumors.
    Han S; Xuan Y; Liu S; Zhang M; Jin D; Jin R; Lin Z
    Pathol Int; 2009 Jul; 59(7):443-7. PubMed ID: 19563407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The relation of peroxisome proliferator activated receptorbeta and Epithelial Ovarian Carcinoma].
    Yang Y; Hou JQ; Ju HW; Yu ZH; Zhao ZW; Yang S; Yang HJ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jul; 23(7):630-2. PubMed ID: 17618585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostate-derived Ets factor is overexpressed in serous epithelial ovarian tumors.
    Rodabaugh KJ; Mhawech-Fauceglia P; Groth J; Lele S; Sood AK
    Int J Gynecol Pathol; 2007 Jan; 26(1):10-5. PubMed ID: 17197890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression and clinical significance of vascular endothelial growth factor, cyclooxygenase-2, and Bcl-2 in borderline ovarian tumors.
    Li M; Qi SY; Wang Y; Feng SX; Zhang BZ; Wang R
    Arch Gynecol Obstet; 2005 Jun; 272(1):48-52. PubMed ID: 15682318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. c-FLIPL expression defines two ovarian cancer patient subsets and is a prognostic factor of adverse outcome.
    Bagnoli M; Ambrogi F; Pilotti S; Alberti P; Ditto A; Barbareschi M; Galligioni E; Biganzoli E; Canevari S; Mezzanzanica D
    Endocr Relat Cancer; 2009 Jun; 16(2):443-53. PubMed ID: 19321593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression and clinical role of antiapoptotic proteins of the bag, heat shock, and Bcl-2 families in effusions, primary tumors, and solid metastases in ovarian carcinoma.
    Elstrand MB; Kleinberg L; Kohn EC; Tropé CG; Davidson B
    Int J Gynecol Pathol; 2009 May; 28(3):211-21. PubMed ID: 19620938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Expression of apoptosis and proliferation markers in progression of ovarian cancer].
    Antoneeva II; Petrov SB
    Patol Fiziol Eksp Ter; 2008; (4):6-7. PubMed ID: 19198263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.